ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
방사선 종양학 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 9.3%로 125억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 정밀치료에 대한 수요 증가, 외래 암센터 확대, 치료계획 소프트웨어 채택 확대, 암 치료에 대한 정부 이니셔티브 증가, 헬스케어 인프라 확대 등의 요인에 기인한 것으로 보입니다. 이 기간의 주요 동향으로는 맞춤형 치료 계획, 고화질 영상, AI 탑재 영상, 정위적 체부 방사선 치료(SBRT)의 발전, 근접방사선치료의 발전 등이 있습니다.
암 환자의 증가는 향후 몇 년 동안 방사선 종양학 시장의 성장을 견인할 것으로 예상됩니다. 암은 체내 비정상적인 세포의 통제할 수 없는 증식과 확산을 특징으로 하며, 환자 수가 증가하고 있습니다. 이러한 증가는 주로 암 발병 위험을 크게 증가시키는 건강에 해로운 생활 습관의 보급에 기인합니다. 방사선 종양학은 고에너지 방사선을 이용하여 암세포를 파괴하고, 종양을 축소하고, 증상을 완화하고, 수술이나 화학요법의 효과를 높여 암 치료에 기여하고 있습니다. 첨단 방사선 기술은 정확도와 치료 성적을 더욱 향상시키고 있습니다. 예를 들어, 2024년 10월 영국 정부 기관인 국민보건서비스(NHS)는 2022년에 새로 암 진단을 받은 환자 수가 34만 6,217명으로 하루 평균 948명이라고 보고했습니다. 이는 2021년 32만 9,664건에서 5% 증가한 수치입니다. 결과적으로 암 환자 수의 증가가 방사선 종양학 시장의 성장에 기여하고 있습니다.
방사선 종양학 시장의 주요 기업들은 다양한 암 치료에서 치료 정확도 향상, 부작용 최소화, 환자 예후 개선을 위해 AI를 활용한 영상 처리 기술 및 적응 기술을 통합한 첨단 방사선 치료 시스템 개발에 주력하고 있습니다. 영상 진단, 조사, 모니터링 등 방사선 치료의 측면을 강화하기 위해 인공지능 기술을 활용합니다. 예를 들어, 스웨덴에 본사를 둔 의료 기술 기업 Elektar는 2024년 5월 방사선 치료 기술을 개선하기 위해 고화질의 AI 강화 이미징을 특징으로 하는 최신 CT-Linac인 Evo를 발표했습니다. 이 다재다능한 시스템은 오프라인 및 온라인 적응형 방사선 치료와 첨단 영상 유도 방사선 치료를 모두 지원하며, 임상의가 환자 개개인에 맞게 치료를 맞춤화할 때 더 높은 정확도와 유연성을 제공합니다. 이 혁신은 치료의 정확성과 적응성을 최적화하여 환자의 예후를 개선하는 것을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 방사선 종양학 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 방사선 종양학 시장 : 성장률 분석
세계의 방사선 종양학 시장 실적 : 규모와 성장, 2019-2024
세계의 방사선 종양학 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 방사선 종양학 전체 시장(TAM)
제6장 시장 세분화
세계의 방사선 종양학 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
외부 방사선 치료
내부 조사 요법
세계의 방사선 종양학 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
전립선암
유방암
폐암
두경부암
대장암
자궁경부암
부인과암
기타 용도
세계의 방사선 종양학 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
암 조사 기관
기타 최종사용자
세계의 방사선 종양학 시장 내부 조사 방사선 치료 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
근접 방사선 치료
강내 밀봉 근접치료
조직내 근접치료
강내 근접 방사선 치료
세계의 방사선 종양학 시장 외부 방사선 치료 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
3D 컨포멀 방사선 치료(3D CRT)
강도 변조 방사선 치료(IMRT)
정위방사선 수술(SRS)
정위방사선 치료(SBRT)
영상 유도 방사선 치료(IGRT)
제7장 지역별·국가별 분석
세계의 방사선 종양학 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 방사선 종양학 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
방사선 종양학 시장 : 경쟁 구도
방사선 종양학 시장 : 기업 개요
Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
Varian Medical Systems Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Shimadzu Corporation
Elekta AB
Mirion Technologies
Ion Beam Applications(IBA)
Accuray Incorporated
Canon Medical Systems
Eckert & Ziegler BEBIG
ViewRay Inc.
MDS Nordion
Mevion Medical Systems
PTW-Freiburg
Toshiba Medical Systems
CivaTech Oncology
ProTom International
Radcal Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
방사선 종양학 시장 2029 : 새로운 기회를 제공하는 국가
방사선 종양학 시장 2029 : 새로운 기회를 제공하는 부문
방사선 종양학 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Radiation oncology is a specialized field of medicine that uses high-energy radiation to treat cancer by damaging the deoxyribonucleic acid (DNA) of malignant cells, thereby inhibiting their growth and spread. This approach employs advanced techniques to deliver precise treatment, focusing on targeting the affected area while minimizing damage to surrounding healthy tissues.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary types of radiation oncology include external beam radiation therapy and internal beam radiation therapy. Internal beam radiation therapy, also known as brachytherapy, involves placing radioactive material directly into or near a tumor to deliver concentrated, localized radiation. It is used in the treatment of various cancers, including prostate, breast, lung, head and neck, colorectal, cervical, gynecological cancers, and others. Key end users of this treatment include hospitals, cancer research institutes, and other healthcare facilities.
The radiation oncology market research report is one of a series of new reports from The Business Research Company that provides radiation oncology market statistics, including radiation oncology industry global market size, regional shares, competitors with a radiation oncology market share, detailed radiation oncology market segments, market trends and opportunities, and any further data you may need to thrive in the radiation oncology industry. This radiation oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The radiation oncology market size has grown strongly in recent years. It will grow from$7.99 billion in 2024 to $8.75 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to factors such as the rising incidence of cancer, increased healthcare spending, growth in healthcare infrastructure investments, an aging population, and a higher prevalence of complex cancer cases.
The radiation oncology market size is expected to see strong growth in the next few years. It will grow to$12.51 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth during the forecast period can be attributed to factors such as the growing demand for precision treatments, the expansion of outpatient cancer centers, increased adoption of treatment planning software, rising government initiatives in cancer care, and expanding healthcare infrastructure. Key trends during this period include personalized treatment plans, high-definition imaging, AI-powered imaging, advancements in stereotactic body radiation therapy (SBRT), and progress in brachytherapy.
The increasing number of cancer cases is expected to drive the growth of the radiation oncology market in the coming years. Cancer, characterized by the uncontrolled growth and spread of abnormal cells in the body, affects a growing number of patients. This rise is primarily due to the widespread adoption of unhealthy lifestyles that significantly heighten the risk of developing cancer. Radiation oncology helps treat cancer by utilizing high-energy radiation to destroy cancer cells, shrink tumors, alleviate symptoms, and enhance the effectiveness of surgery and chemotherapy. Advanced radiation techniques have further improved precision and outcomes. For example, in October 2024, the National Health Service (NHS), a UK-based government body, reported that there were 346,217 new cancer diagnoses in 2022, averaging 948 per day. This marked a 5% increase from the 329,664 diagnoses in 2021. As a result, the rising number of cancer cases is contributing to the growth of the radiation oncology market.
Leading companies in the radiation oncology market are focusing on developing advanced radiation therapy systems that incorporate AI-powered imaging and adaptive technologies to improve treatment precision, minimize side effects, and enhance patient outcomes for various cancer treatments. AI-powered radiotherapy leverages artificial intelligence technologies to enhance aspects of radiation therapy, including treatment planning, imaging, delivery, and monitoring. For example, in May 2024, Elekta, a Sweden-based medical technology company, introduced Evo, its latest CT-Linac, which features high-definition AI-enhanced imaging designed to refine radiation therapy techniques. This versatile system supports both offline and online adaptive radiation therapy as well as advanced image-guided radiation therapy, offering clinicians greater precision and flexibility in customizing treatments for individual patients. The innovation aims to improve patient outcomes by optimizing the accuracy and adaptability of treatments.
In June 2024, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, acquired Fusion Pharmaceuticals for an undisclosed sum. With this acquisition, AstraZeneca seeks to strengthen its oncology portfolio by incorporating Fusion's innovative radioconjugate (RC) technology, particularly for enhancing targeted cancer therapies such as FPI-2265 for metastatic castration-resistant prostate cancer (mCRPC). The goal is to advance precision oncology and reduce dependence on traditional treatments. Fusion Pharmaceuticals, a clinical-stage oncology company based in Canada, focuses on developing next-generation radiopharmaceuticals as precision medicines.
Major players in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, and ScandiDos.
North America was the largest region in the radiation oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiation oncology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the radiation oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The radiation oncology market consists of revenues earned by entities by providing services such as tumor board consultations, radiation oncology equipment maintenance, telemedicine consultations, stereotactic radiosurgery (SRS), and image-guided radiation therapy (IGRT). The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation oncology market also includes sales of radiation therapy equipment, treatment planning software, dosimetry systems, radiation protection products, and medical consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Radiation Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on radiation oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for radiation oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiation oncology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Cervical Cancer; Gynecological Cancer; Other Applications
3) By End-User: Hospitals; Cancer Research Institutes; Other End-Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Radiation Oncology Market Characteristics
3. Radiation Oncology Market Trends And Strategies
4. Radiation Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Radiation Oncology Growth Analysis And Strategic Analysis Framework
5.1. Global Radiation Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Radiation Oncology Market Growth Rate Analysis
5.4. Global Radiation Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Radiation Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Radiation Oncology Total Addressable Market (TAM)
6. Radiation Oncology Market Segmentation
6.1. Global Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Beam Radiation Therapy
Internal Beam Radiation Therapy
6.2. Global Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostate Cancer
Breast Cancer
Lung Cancer
Head And Neck Cancer
Colorectal Cancer
Cervical Cancer
Gynecological Cancer
Other Applications
6.3. Global Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cancer Research Institutes
Other End-Users
6.4. Global Radiation Oncology Market, Sub-Segmentation Of Internal Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Brachytherapy
Endocavitary Brachytherapy
Interstitial Brachytherapy
Intraluminal Brachytherapy
6.5. Global Radiation Oncology Market, Sub-Segmentation Of External Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
3D Conformal Radiation Therapy (3DCRT)
Intensity-Modulated Radiation Therapy (IMRT)
Stereotactic Radiosurgery (SRS)
Stereotactic Body Radiation Therapy (SBRT)
Image-Guided Radiation Therapy (IGRT)
7. Radiation Oncology Market Regional And Country Analysis
7.1. Global Radiation Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Radiation Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
